기본 정보
- CAS
1423073-21-5- 표준 SMILES
COC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1- InChIKey
ADMYVFYYALQDPK-QYVSTXNMSA-N- 분자식
- C15H17N7O6
- 평균 분자량
- 391.34 g/mol
이름 및 식별자
- 우선 이름
- 2-(4-Methoxycarbonylpyrazol-1-yl)adenosine
- IUPAC
- methyl 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]pyrazole-4-carboxylate
- 영어명
- Regadenoson Impurity 3
- 분자식
- C15H17N7O6
- 분자량
- 391.34
이름 및 동의어
2-(4-methoxycarbonylpyrazol-1-yl)adenosineRefChem:457906937-145-2Regadenoson Impurity 31423073-21-5methyl 1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-yl)-1H-pyrazole-4-carboxylateCJ6K5C4JMBSCHEMBL14719373ADMYVFYYALQDPK-QYVSTXNMSA-N2-[4-(Methoxycarbonyl)-1H-pyrazol-1-yl]adenosineMethyl 1-(6-amino-9-beta-D-ribofuranosyl-9H-purin-2-yl)-1H-pyrazole-4-carboxylate1H-Pyrazole-4-carboxylic acid, 1-(6-amino-9-beta-D-ribofuranosyl-9H-purin-2-yl)-, methyl ester
이름 더 보기
1H-Pyrazole-4-carboxylic acid, 1-(6-amino-9-β-D-ribofuranosyl-9H-purin-2-yl)-, methyl esterethyl 1-(9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-methoxy-9H-purin-2-yl)-1H-pyrazole-4-carboxylate
데이터베이스 식별자
- CAS
1423073-21-5- PubChem CID
- 71270364
- UNII
- CJ6K5C4JMB
- EC Number
- 937-145-2
물성
구조 계산 물성
- XLogP
- -0.9
- 극성 표면적
- 184 Ų
- 수소 결합 공여자 수
- 4
- 수소 결합 수용자 수
- 11
- 회전 가능 결합 수
- 5
- 무거운 원자 수
- 28
- 형식 전하
- 0
- 복잡도
- 587
물리화학적 성질
- 끓는 점
- 832.2 · 832.2±75.0 °C(Predicted)
- 밀도
- 1.97 · 1.97±0.1 g/cm3(Predicted)
- 산도 계수 (pKa)
- 13.07 · 13.07±0.70(Predicted)
안전 및 규제
GHS 분류
GHS Classification
Danger
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P308+P316, P317, P321, P330, P332+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
유해성 정보
Hazard Classes and CategoriesAcute Tox. 4 (100%)
화학 및 산업
상·하류 제품 정보
상류 원료
공급사16 곳
广州佳途科技股份有限公司81960175 18933936954 · [email protected]
广州隽唐科技有限公司020-36607679 13502246435 · [email protected]
孟成科技(上海)有限公司400-820-6829 · [email protected]
希瓦生物科技(广州)有限公司13268215580 · [email protected]
湖北扬信医药科技有限公司15347293736 · [email protected]
常州翔龙医药科技有限公司18915873328 18915873328 · [email protected]
深圳摩科生化科技有限公司18627923403 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]
连云港腾发生物科技有限公司0518-85475186 18705131893 · [email protected]
上海福来伊得医药科技有限公司13382092506 15312065189 · [email protected]
湖北摩科生物科技有限公司18576690171 · [email protected]
深圳市华信医药科技有限公司15671363360 · [email protected]
湖北摩科化学有限公司18627753421; 18627756402 · [email protected]
深圳市恒丰万达医药科技有限公司18126517264 · [email protected]
湖北摩科生物科技有限公司17320513646 · [email protected]
ShenZhen H&D Pharmaceutical Technology Co., LTD+86-18627948422 · [email protected]
관련 반응
1건
화합물 노트
불러오는 중…